关于我们

欢迎来到泽塔制药

泽溚制药是一家快速发展的埃及公司,成立于2010年,旨在代表制药行业的附加值。

泽塔制药在所有治疗领域都有精心挑选的独特产品组合。

泽制药已于2015年开始其丙型肝炎病毒(索非布韦、泽塔西弗和索磷布韦)产品的营销活动

泽塔制药与埃及卫生部和埃及肝脏研究所合作,成功治疗了60000多名患者,治愈率95%,与全球治愈率相似。

我们的使命与愿景

Our Vision

我们努力成为最受社区信任的制药合作伙伴之一,关心中东-非洲地区人民的生活质量

Our Mission

我们致力于为整个中东非洲地区的社区提供价格合理、高质量的制药综合解决方案 我们最先进的生产设施旨在符合良好生产规范和世界卫生组织标准。 泽塔制药还通过吸引、培养和保留优秀人才来投资人力资本,并热情致力于泽塔制药的职业道德和强大的核心价值观。 。将市场上最尖端的科学与最优秀的人才相结合,使我们能够成为医疗体系中可靠的合作伙伴。

泽塔制药厂

泽塔制药 拥有业内最广泛的优质产品组合之一,并且对未来持乐观态度, 董事会决定在 7500 平方米的区域内建立一个符合 良好生产规范 标准的生产设施。

泽塔历史

Cool Timeline

2022
9月

2022 launched New 9 Products

2022 launched New 9 Products

1-Nexirozova Launch:

Jan – 2022, Zeta Pharma launched Nexirozova; a new generic of the anti-dyslipidemic molecule Rosuvastatin 5,10,20mg,

Click Here To See More.

2021
12月

2021 Launched New 7 Products

2021 Launched New 7 Products

1- Bilastegic Launch:

Jan – 2021, Zeta Pharma launched its new product, Bilastegic the world’s latest and most effective product for allergic diseases,

Click Here To See More.

2020
7月

EBRD Agreement 2020

EBRD Agreement 2020

The European Bank for Reconstruction and Development (EBRD) is providing consultancy studies to Zeta Pharma factory in Egypt to qualify for European GMP accreditation.

Click Here To See More.

4月

2020 Launched New 4 Products

2020 Launched New 4 Products

1- Empacoza Lunch:

Zeta Pharma launches “Empacoza” type 2 diabetes medicine in the Egyptian Market, In presence of famous Egyptian professors of Internal medication and endocrinology,

Click Here To See More.

2019
5月

2019 Launched New 5 Products

2019 Launched New 5 Products

1- Ancavaz Launch:

Zeta launched Ancavaz -which is indicated as a substitution therapy for the treatment of hypertension and/or stable coronary heart disease,

Click Here To See More.

2018
10月

2018 Launched 4 New Products

2018 Launched 4 New Products

1- Nexicure Launch:

12/10/2018

Zeta launched Nexicure Esomeprazole 20/40 mg MUPS tablet,

Click Here To See More.

2017
12月

100 Millions Seha

100 Millions Seha

Interview with Major General Mahmoud Ashmawi, Governor of Qalyubia governorate, and Dr. Hamdi El Tabakh, the Ministry of Health representative in Qalyubia in the launch of the Hepatitis C eradication campaign,

Click Here To See More.

2015
12月

HCV Launch

HCV Launch

Zeta Pharma Has started its marketing activities in 2015 on the products for Hepatitis C Virus (Sofocivir, Zetaciver & Sofocivir Plus).

Click Here To See More.